BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Rimini Street
RMNI
$445M
| $15.4K | ﹤0.01% |
2,502
-77
| -3% | -$563 |
|
3477
Orion Energy Systems
OESX
$84.2M
| $15.4K | ﹤0.01% |
269
-67
| -20% | -$4.07K |
|
3478
Arq
ARQ
$100M
| $15.3K | ﹤0.01% |
2,062
-7,159
| -78% | -$44.1K |
|
3479
Franklin Covey
FC
$234M
| $15.3K | ﹤0.01% |
472
-1,200
| -72% | -$37K |
|
3480
Ooma
OOMA
$553M
| $15.2K | ﹤0.01% |
805
-1,922
| -70% | -$34.8K |
|
3481
Champions Oncology
CSBR
$68.8M
| $15.2K | ﹤0.01% |
1,474
+701
| +91% | +$7.11K |
|
|
AE
3482
DELISTED
Adams Resources & Energy Inc
AE
| $15.1K | ﹤0.01% |
545
-830
| -60% | -$22.9K |
|
3483
Caledonia Mining Corp
CMCL
$441M
| $15.1K | ﹤0.01% |
1,244
-2,727
| -69% | -$38.3K |
|
|
GSKY
3484
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $15K | ﹤0.01% |
2,702
-5,500
| -67% | -$32.9K |
|
3485
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $15K | ﹤0.01% |
1,074
-2,425
| -69% | -$36.8K |
|
3486
Electromed
ELMD
$352M
| $14.9K | ﹤0.01% |
1,321
-240
| -15% | -$2.46K |
|
|
WMC
3487
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $14.8K | ﹤0.01% |
455
-2,578
| -85% | -$85.4K |
|
3488
Regional Management Corp
RM
$297M
| $14.8K | ﹤0.01% |
317
-3,574
| -92% | -$155K |
|
3489
Western New England Bancorp
WNEB
$282M
| $14.5K | ﹤0.01% |
1,776
-8,732
| -83% | -$72.2K |
|
3490
Apyx Medical
APYX
$126M
| $14.4K | ﹤0.01% |
1,397
-11,665
| -89% | -$116K |
|
3491
C&F Financial
CFFI
$288M
| $14.4K | ﹤0.01% |
282
-1,351
| -83% | -$63.4K |
|
3492
Century Casinos
CNTY
$34.3M
| $14.2K | ﹤0.01% |
1,056
-13,348
| -93% | -$174K |
|
3493
Commercial Vehicle Group
CVGI
$128M
| $14.2K | ﹤0.01% |
+1,334
| New | +$14.8K |
|
3494
AquaBounty Technologies
AQB
$7.1M
| $14.2K | ﹤0.01% |
132
+131
| +13,100% | +$15K |
|
3495
Neuronetics
STIM
$223M
| $14.2K | ﹤0.01% |
+884
| New | +$12.2K |
|
|
HYRE
3496
DELISTED
HyreCar Inc. Common Stock
HYRE
| $14.1K | ﹤0.01% |
+675
| New | +$10.4K |
|
|
IMDX
3497
Insight Molecular Diagnostics
IMDX
$147M
| $14.1K | ﹤0.01% |
123
-330
| -73% | -$32.2K |
|
|
SCTL
3498
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $14.1K | ﹤0.01% |
6,095
+1,699
| +39% | +$4.31K |
|
|
LUNA
3499
DELISTED
Luna Innovations Incorporated
LUNA
| $14.1K | ﹤0.01% |
1,300
-2,657
| -67% | -$28.9K |
|
|
KIN
3500
DELISTED
Kindred Biosciences, Inc.
KIN
| $14.1K | ﹤0.01% |
1,535
-3,638
| -70% | -$21.2K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.